BROWN BROTHERS HARRIMAN & CO – Abbott Laboratories Transaction History
BROWN BROTHERS HARRIMAN & CO portfolio value:
$217.65M
portfolio value
BROWN BROTHERS HARRIMAN & CO quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.28% | 6.18K shares | -26.07M | $96.76 | 2.24M |
Q2 2022 | share | Decrease | -2.32% | -53.16K shares | -28.07M | $108.65 | 2.24M |
Q1 2022 | share | Increase | +2.77% | 61.84K shares | -42.69M | $118.36 | 2.29M |
Q4 2021 | share | Decrease | -0.67% | -15.15K shares | 48.73M | $141 | 2.23M |
Q3 2021 | share | Decrease | -2.54% | -58.63K shares | -1.84M | $117.68 | 2.24M |
Q2 2021 | share | Increase | +0.41% | 9.52K shares | -7.88M | $115.05 | 2.30M |
Q1 2021 | share | Increase | +1351.44% | 2.14M shares | 258.14M | $118.49 | 2.29M |
Q4 2020 | share | Decrease | -1.69% | -2.73K shares | -193K | $107.81 | 158.38K |
Q3 2020 | share | Increase | +2.08% | 3.28K shares | 3.10M | $106.81 | 161.11K |
Q2 2020 | share | Increase | +1.06% | 1.65K shares | 2.10M | $89.39 | 157.82K |
Q1 2020 | share | Decrease | -6.08% | -10.11K shares | -2.12M | $76.84 | 156.16K |
Q4 2019 | share | Increase | +0.37% | 609 shares | 581K | $84.23 | 166.28K |
Q3 2019 | share | Decrease | -0.52% | -873 shares | -145K | $80.81 | 165.67K |
Q2 2019 | share | Decrease | -2.94% | -5.04K shares | 290K | $80.92 | 166.54K |
Q1 2019 | share | Increase | +11.08% | 17.12K shares | 2.54M | $76.6 | 171.58K |
Q4 2018 | share | Increase | +29.79% | 35.45K shares | 2.44M | $68.98 | 154.46K |
Q3 2018 | share | Increase | +0.88% | 1.04K shares | 1.53M | $69.69 | 119.01K |
Q2 2018 | share | Decrease | -3.27% | -3.98K shares | -112K | $57.68 | 117.96K |
Q1 2018 | share | Decrease | -3.62% | -4.58K shares | 86K | $56.4 | 121.95K |
Q4 2017 | share | Decrease | -9.01% | -12.53K shares | -200K | $53.46 | 126.53K |
Q3 2017 | share | Decrease | -9.43% | -14.47K shares | -43K | $49.74 | 139.06K |
Q2 2017 | share | Decrease | -0.07% | -112 shares | 640K | $45.07 | 153.54K |
Q1 2017 | share | Decrease | -1.51% | -2.36K shares | 831K | $40.93 | 153.65K |
Q4 2016 | share | Decrease | -5.17% | -8.49K shares | -964K | $35.17 | 156.01K |
Q3 2016 | share | Decrease | -11.37% | -21.11K shares | -340K | $38.48 | 164.51K |
Q2 2016 | share | Increase | +0.81% | 1.48K shares | -406K | $35.55 | 185.62K |
Q1 2016 | share | Increase | +2.17% | 3.91K shares | -391K | $37.6 | 184.14K |